Human Immunodeficiency Virus 1 (HIV-1) PhenoSense Entry® (Monogram® Fuzeon Resistance)

Methodology: 
Polymerase chain reaction (PCR) amplification and viral culture
Performed: 
Monday - Friday
Use: 
This test is used to determine a patient's phenotypic susceptibility to enfuvirtide (Fuzeon®) and assesses likely effectiveness before enfuvirtide is added to that person's regimen or before changing a regimen that includes enfuvirtide.
 

Limitations

This procedure should be used for patients with documented HIV-1 infection and viral loads ≥ 1,000 copies/mL.
Specimen Requirements: 
Type: Plasma, frozen
 
Container/Tube: Lavender-top tube (EDTA) or plasma-preparation tube (PPT)

Sample Volume: 3 mL

Minimum Volume: 1.1 mL

Storage: Freeze specimens immediately after collection.
 
Rejection Criteria:
  • Insufficient volume
  • Heparinized plasma
  • Non-frozen specimens
  • PPT not centrifuged
CPT Code (s): 
87903
Notes: 

UFHPL Test #: 18015

Collection procedure: 
  • Collect specimens in two lavender-top tubes (EDTA) or two PPT tubes. Do not use green-top tubes (heparin).
     
  • Centrifuge specimens within six hours of collection.
     
  • Transfer the collected plasma to one or more polypropylene screw-capped tubes and freeze it.
     
  • Ship specimens frozen. To avoid delays in turnaround time, when requesting multiple tests on frozen samples, submit separate frozen specimens for each test requested.
Test Directory